semaglutide and parkinson's disease Glucagon-like peptide-1 medicines in neurological psychiatric disorders: Cell Reports Medicine What happens when patients stop

Many GLP-1 medications (Ozempic, Mounjaro) were first approved for diabetes treatment, then later approved for obesity under different brand names (Wegovy, Zepbound)

It is important to discuss any side effects with a healthcare provider to ensure the benefits of the medication outweigh the risks

Step 6: Slowly depress the plunger until all the solution is injected, then withdraw the needle smoothly

Key Scientific Applications GLP-1S is a long-acting GLP-1 receptor agonist designed to mimic endogenous glucagon-like peptide-1 signaling

Most patients experience improvement in these symptoms over time as physiological adaptation occurs